American Century Companies’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

American Century Companies's LKFT Position: Q1 2026 in Review

American Century Companies increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 45% in Q1 2026, buying an estimated $399K and bringing the position to 38,790 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2287.

American Century Companies first reported a position in LKFT in Q1 2020 and has held it in 20 quarters since. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

• American Century Companies held 38,790 shares of Lakefront Biotherapeutics American Depositary Shares worth $1.16M as of Q1 2026.
• American Century Companies bought 12,061 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $399K.
• Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2287 holding.
• American Century Companies first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2020 and has held it in 20 quarters since.
• 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.